RecruitingNCT07251049

Acute Infectious Encephalitis and Myelitis in Guadeloupe by New Generation Sequencing

Acute Infectious Encephalitis and Myelitis in Guadeloupe by New Generation Sequencing Acute Infectious Encephalitis and Myelitis in Guadeloupe by New Generation Sequencing


Sponsor

Centre Hospitalier Universitaire de la Guadeloupe

Enrollment

100 participants

Start Date

Nov 16, 2023

Study Type

OBSERVATIONAL

Conditions

Summary

: Encephalitis or myelitis is defined as the inflammatory or infectious involvement of the cerebral parenchyma or spinal cord. When an infectious origin is suspected, the germ is not always identified. Next-generation sequencing could be used to correct an etiological diagnosis of these severe conditions in Guadeloupe. The rate of cases for which the infectious agent is not identified encourages continued diagnostic efforts, with the objective of identifying new pathogens or emerging pathogens, some of which may be more specific in the tropics.


Eligibility

Min Age: 28 Days

Plain Language Summary

Simplified for easier understanding

This clinical trial is studying a new treatment for people with acute encephalitis and acute myelitis. The study is currently recruiting participants at 1 location. People eligible for this study include aged 28 Days and older.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.


Locations(1)

Centre Hospitalier Universitaire de la Guadeloupe

Pointe-à-Pitre, Guadeloupe, Guadeloupe

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT07251049